Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $27.3 million.

  • CervoMed's Cash & Current Investments fell 6034.9% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 million, marking a year-over-year decrease of 6034.9%. This contributed to the annual value of $38.9 million for FY2024, which is 39945.83% up from last year.
  • According to the latest figures from Q3 2025, CervoMed's Cash & Current Investments is $27.3 million, which was down 6034.9% from $33.5 million recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Cash & Current Investments peaked at $68.8 million during Q3 2024, and registered a low of $6.4 million during Q1 2024.
  • Its 4-year average for Cash & Current Investments is $27.3 million, with a median of $27.3 million in 2025.
  • Over the last 5 years, CervoMed's Cash & Current Investments had its largest YoY gain of 56031.56% in 2024, and its largest YoY loss of 6388.82% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Cash & Current Investments stood at $16.5 million in 2022, then plummeted by 52.78% to $7.8 million in 2023, then skyrocketed by 399.46% to $38.9 million in 2024, then fell by 29.87% to $27.3 million in 2025.
  • Its last three reported values are $27.3 million in Q3 2025, $33.5 million for Q2 2025, and $35.2 million during Q1 2025.